EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Umbilical Cord Mesenchymal Stem Cell Secretome: A Potential Regulator of B Cells in Systemic Lupus Erythematosus

Adelina Yordanova, Mariana Ivanova, Kalina Tumangelova-Yuzeir, Alexander Angelov iD, Stanimir Kyurkchiev, Kalina Belemezova iD, Ekaterina Kurteva iD, Dobroslav Kyurkchiev, Ekaterina Ivanova-Todorova

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Adelina Yordanova und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital St. Ivan Rilski, Laboratory of Clinical Immunology, Department of Clinical Immunology, Medical Faculty, Medical University of Sof…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells, Umbilical Cord, B-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Sofia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases represent a severe personal and healthcare problem that seeks novel therapeutic solutions. Mesenchymal stem cells (MSCs) are multipotent cells with interesting cell biology and promising therapeutic potential. The immunoregulatory effects of secretory factors produced by umbilical cord mesenchymal stem cells (UC-MSCs) were assessed on B lymphocytes from 17 patients with systemic lupus erythematosus (SLE), as defined by the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for SLE, and 10 healthy volunteers (HVs). Peripheral blood mononuclear cells (PBMCs) from patients and HVs were cultured in a UC-MSC-conditioned medium (UC-MSCcm) and a control medium. Flow cytometry was used to detect the surface expression of CD80, CD86, BR3, CD40, PD-1, and HLA-DR on CD19+ B cells and assess the percentage of B cells in early and late apoptosis. An enzyme-linked immunosorbent assay (ELISA) quantified the production of BAFF, IDO, and PGE2 in PBMCs and UC-MSCs. Under UC-MSCcm influence, the percentage and mean fluorescence intensity (MFI) of CD19+BR3+ cells were reduced in both SLE patients and HVs. Regarding the effects of the MSC secretome on B cells in lupus patients, we observed a decrease in CD40 MFI and a reduced percentage of CD19+PD-1+ and CD19+HLA-DR+ cells. In contrast, in the B cells of healthy participants, we found an increased percentage of CD19+CD80+ cells and decreased CD80 MFI, along with a decrease in CD40 MFI and the percentage of CD19+PD-1+ cells. The UC-MSCcm had a minimal effect on B-cell apoptosis. The incubation of patients’ PBMCs with the UC-MSCcm increased PGE2 levels compared to the control medium. This study provides new insights into the impact of the MSC secretome on the key molecules involved in B-cell activation and antigen presentation and survival, potentially guiding the development of future SLE treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMesenchymal Stem CellsUmbilical CordB-LymphocytesSecretomeHumansFemaleAdultMaleLeukocytes, MononuclearCells, CulturedApoptosisCulture Media, ConditionedMiddle Aged

Stichwörter der Autor:innen

B lymphocytesB-cell activating factor receptormesenchymal stem cellssystemic lupus erythematosus

Substanzen

Culture Media, Conditioned

Autor:innen und Institutionen

  • University Hospital St. Ivan Rilski, Laboratory of Clinical Immunology, Department of Clinical Immunology, Medical Faculty, Medical University of Sofia, 15 Akademik Iv. E. Geshov Blvd., 1431 Sofia, Bulgaria.
  • University Hospital St. Ivan Rilski, Clinic of Rheumatology, Department of Rheumatology, Medical Faculty, Medical University of Sofia, 13 Urvich St., 1612 Sofia, Bulgaria.
  • Tissue Bank BulGen, 1330 Sofia, Bulgaria.

ORCID-Profile: Alexander Angelov, Kalina Belemezova, Ekaterina Kurteva

Förderung

  • Medical University of Sofia

Zitieren

APA

Yordanova, A., Ivanova, M., Tumangelova-Yuzeir, K., Angelov, A., Kyurkchiev, S., Belemezova, K., Kurteva, E., Kyurkchiev, D., & Ivanova-Todorova, E. (2024). Umbilical Cord Mesenchymal Stem Cell Secretome: A Potential Regulator of B Cells in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312515

Vancouver

Yordanova A, Ivanova M, Tumangelova-Yuzeir K, Angelov A, Kyurkchiev S, Belemezova K, et al. Umbilical Cord Mesenchymal Stem Cell Secretome: A Potential Regulator of B Cells in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312515

BibTeX
@article{Yordanova2024,
  author = {Yordanova, Adelina and Ivanova, Mariana and Tumangelova-Yuzeir, Kalina and Angelov, Alexander and Kyurkchiev, Stanimir and Belemezova, Kalina and Kurteva, Ekaterina and Kyurkchiev, Dobroslav and Ivanova-Todorova, Ekaterina},
  title = {Umbilical Cord Mesenchymal Stem Cell Secretome: A Potential Regulator of B Cells in Systemic Lupus Erythematosus},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312515}
}
Kostenlos starten →